Details of the Drug Reposition

General Information of This Drug (ID: DM8R3GM)

Drug Name
KDT-501   DM8R3GM
Synonyms Protein kinase inhibitor (inflammatory disorders), KinDex Therapeutics; Protein kinase inhibitor (metabolic disorders),KinDex Therapeutics
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Inflammation DISJUQ5T 1A00-CA43.1 Phase 2 [1]
Type-2 diabetes DIS3X247 5A11 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02444910) Effects of KDT501 on Metabolic Features in Insulin Resistant Subjects. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)